Скачать или смотреть Navigating the Complexity: GenScript’s End-to-End Solutions for Bispecific Antibody Discovery

Abstract: Bispecific antibody drug development is a complex process requiring careful consideration of target biology, mechanism of action, antibody format, and other critical factors. Leveraging advanced technologies and strategic planning can help navigate these challenges and lead to successful therapeutic outcomes. Join Amanda as she discusses GenScript’s integrated technologies that will support your bispecific design, expression, and ensure your developability.

Speaker: Amanda Grimm
Job Title: Sr. Segment Marketing Manager
Company: GenScript USA Inc
Bio:Amanda Grimm is a seasoned life sciences professional with a diverse background spanning immunopathology research, immunoassay development, manufacturing, and commercialization. Since joining GenScript in 2021, she has led strategic marketing initiatives for the company’s antibody drug discovery portfolio, helping researchers accelerate their therapeutic development.

Before transitioning into marketing, Amanda worked extensively in immunopathology research, focusing on animal diseases and the development of immunoassays for both research and commercial applications. Her expertise extends to product management of automation technologies and diagnostics, giving her a well-rounded perspective on the scientific and business aspects of biopharma innovation.

At GenScript, Amanda drives portfolio education and global marketing campaigns to support researchers in navigating the complexities of antibody drug development. She is passionate about translating cutting-edge technologies into impactful solutions that empower scientists to bring novel therapeutics to market.

Amanda holds dual Bachelor of Science degrees in Microbiology and Biochemistry, as well as a Professional Science Master’s (PSM) from Washington State University.